Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson's disease
Published on 08/07/2025 at 18:07 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/vesper-bio-awarded-grant-by-the-michael-j-fox-foundation-to-assess-sortilin-inhibitors-in-the-treatment-of-parkinsons-disease-302040660.html
en | boerse | 67940725 |
